An experimental Alnylam drug substantially cut the risk of death and serious cardiovascular complications among patients with ...
Patients, especially in Black and brown communities, have had delivery plans upended and are scrambling for solutions. 17 of ...
After decades of anti-vaccine rhetoric, RFK Jr. pivots to chronic diseases — and gets Trump on board
The quiz highlights what has become a central focus of Kennedy’s political life: chronic disease, particularly among children ...
Use of the weight loss drug Wegovy cut the chances of patients dying from Covid by roughly a third compared to placebo, a new ...
First, individual market health insurance became unaffordable after the Affordable Care Act (ACA) imposed regulations on ...
Novo Nordisk’s Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a ...
If H5N1 bird flu in cattle is confirmed at three dairy farms in California's Central Valley, they would be the first cases in ...
Emissions from asthma inhalers in 2022 could power all the homes in a city the size of Milwaukee for an entire year.
The chairman of a U.S. congressional panel investigating pharmacy benefit managers accused top industry executives of making false statements in testimony last month, Bloomberg Law reports. House ...
The Readout LOUD podcast discusses gene therapy pioneer Jim Wilson's next act, and Eli Lilly's plan to sell weight loss drugs in vials to consumers.
In today's health and life science news, what more GLP-1 means for telehealth companies; good news on kidney transplants, cardiology studies, and the benefits of sleep.
Eli Lilly garnered widespread praise Tuesday for launching discounted versions of its blockbuster obesity drug Zepbound.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results